Dregeoside Aa1 is primarily studied for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in inhibiting pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory conditions. Recent studies suggest it may also possess antiviral effects, particularly against certain enveloped viruses, by interfering with viral entry into host cells. Its application is currently limited to preclinical research, where it serves as a lead compound in developing natural product-derived therapeutics. Due to its glycosidic structure, it is also of interest in studies exploring structure-activity relationships of bioactive plant metabolites.